AbbVie (ABBV) Net Income (2012 - 2026)
AbbVie (ABBV) posted Net Income of $3.62 billion for Q2 2026, up 284.3% from $941 million a year earlier and up 418.8% from the prior quarter.
AbbVie (ABBV) Net Income (2012 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Income at AbbVie was $6.32 billion, up 67.5% year-over-year; for FY2025, it was $4.23 billion, down 1.2% from FY2024.
- Annual Net Income has declined for three consecutive years, with a five-year compound annual growth rate of -1.7% (FY2020 to FY2025).
- In prior years, AbbVie's Net Income was $4.29 billion in FY2024 (-12.0%), $4.87 billion in FY2023 (-58.9%), $11.85 billion in FY2022 (+2.6%) and $11.55 billion in FY2021 (+149.9%).
- The Q2 2026 figure stands as the highest quarterly Net Income since Q3 2022.
- On a year-over-year basis, Net Income increased in 1 of the last six quarters, with growth averaging 16.8%.
- The strongest year-over-year quarter for Net Income in the past five years was Q1 2024, with growth of 469.3%; the weakest was Q1 2023, with a decline of 94.6%.
- According to Business Quant data, Net Income for the three prior quarters was $697 million (Q1 2026), $1.82 billion (Q4 2025) and $188 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Vertex Pharmaceuticals | 129.23 Bn | 101.23 Bn | 2.84 Bn | 1.10 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.62 Bn |
| Mar 31, 2026 | 697.00 Mn |
| Dec 31, 2025 | 1.82 Bn |
| Sep 30, 2025 | 188.00 Mn |
| Jun 30, 2025 | 941.00 Mn |
| Mar 31, 2025 | 1.29 Bn |
| Dec 31, 2024 | -22.00 Mn |
| Sep 30, 2024 | 1.56 Bn |
| Jun 30, 2024 | 1.37 Bn |
| Mar 31, 2024 | 1.37 Bn |
| Dec 31, 2023 | 822.00 Mn |
| Sep 30, 2023 | 1.78 Bn |
| Jun 30, 2023 | 2.03 Bn |
| Mar 31, 2023 | 241.00 Mn |
| Dec 31, 2022 | 2.47 Bn |
| Sep 30, 2022 | 3.95 Bn |
| Jun 30, 2022 | 928.00 Mn |
| Mar 31, 2022 | 4.49 Bn |
| Dec 31, 2021 | 4.04 Bn |
| Sep 30, 2021 | 3.18 Bn |
AbbVie Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=ABBV&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();